Founders Fund Leads Emulate, Inc. in $36 Million Financing Round
Emulate, Inc., secured $36 million in Series C financing led by Founders Fund, as well as new investors ALS Investment Fund, SciFi VC, members of GlassWall Syndicate Association, and existing investors.
Emulate’s automated, lab-ready Human Emulation System is comprised of Organ-Chips, instrumentation, and software applications. The company plans to add advanced biological capabilities to its Organ-Chip products, including the Liver-Chip, Intestine-Chip, Lung-Chip, Brain-Chip, and human-relevant models of thrombosis and immune system modulation.
The company plans to use the funds for broadening functionality and enhancing commercial efforts of its Human Emulation System™ so that pharmaceutical industry researchers can use Organs-on-Chips technology across the entire drug discovery and development process.